comparemela.com

Israel Based Care News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innovative Diagnostic Methods Remains Vital in the Fight Against Cancer

Innovative Diagnostic Methods Remains Vital in the Fight Against Cancer FinancialBuzz.com News Commentary NEW YORK, April 9, 2021 /PRNewswire/ The cancer treatment market is one of the biggest segments of the biotechnology industry. According to the National Cancer Institute, roughly 1.8 million people were diagnosed with cancer in the United States in 2020. Overall, lung and bronchus cancer is the second most common cancer diagnosis with an estimated 228,820 new cases. Prostate cancer is the leading cancer diagnosis among men and the third most common diagnosis overall with 191,930 expected cases. However, the increase in competition and continuous technological advancements has led to improvements in the product portfolios of biotech firms in the field. Therefore, product approvals and product development are one of the key developmental strategies adopted by market players in the global cancer therapeutics market. And, according to a report by Mordor Intelligence, the breast c

Todos Medical Ltd wins Notice of Allowance from European Patent Office for patent covering cancer diagnosis using TBIA Immune Profiling

Todos wins Notice of Allowance from European Patent Office for patent covering cancer diagnosis using TBIA Immune Profiling CEO Gerald E Commissiong said TBIA is a game-changing approach to cancer detection as different AI-developed algorithms run for multiple cancer types on the same blood sample The TBIA method uses blood - plasma, or peripheral blood mononuclear cells - to distinguish between patients with benign tumors versus malignant tumors, in contrast to no tumors Todos Medical Ltd (OTCQB:TOMDF), a medical diagnostics solutions company, revealed that it has received a notice of allowance from the European Patent Office covering the use of the company’s proprietary Total Biochemical Infrared Analysis (TBIA) platform to diagnose cancers.

Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application . Todos Medical Ltd.April 8, 2021 GMT NEW YORK, NY, and REHOVAT, ISRAEL, April 08, 2021 (GLOBE NEWSWIRE) via NewMediaWire    Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics solutions company, today announced that it has received a notice of allowance (‘Letter of Intent to Grant a Patent’) from the European Patent Office covering the use of the Company’s proprietary Total Biochemical Infrared Analysis (‘TBIA’) method that uses blood (plasma and/or peripheral blood mononuclear cells ‘PBMCs’) to distinguish between patients with benign tumors vs. malignant tumors vs. no tumors (healthy controls).

Breaking News: Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform | Breaking News: Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling PlatformFinancial Buzz

Breaking News: Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform | Breaking News: Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling PlatformFinancial Buzz
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.